Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 May 2024 | Story Valentino Ndaba | Photo Supplied
IISLT Conference
Diving deep into the intricacies of land tenure in rural communities at the International Interdisciplinary Security of Land Tenure Conference.

The Law Faculty is excited to host the International Interdisciplinary Security of Land Tenure (IISLT) Conference and extends an invitation for broad online institutional engagement in the event. Participants are encouraged to register early to secure their virtual presence and bookmark the link, which grants access throughout the conference days from 6 to 8 May 2024.


See the attached final conference programme.

Conference Programme

The University of the Free State (UFS), in collaboration with esteemed research partners, will host the IISLT Conference scheduled for 6-8 May 2024 on the Bloemfontein Campus, Equitas Building. The conference aims to address the pervasive issue of insecure land rights plaguing rural communities in South Africa, despite constitutional safeguards and landmark legal decisions.

Transforming the rural land economy

Under the theme Transforming the rural land economy: the creation of secure land rights for the enhancement of rural livelihoods and sustainable development, the conference seeks to explore solutions to the complex challenges surrounding land tenure security.

Dr Anthea-Lee September-Van Huffel, Lecturer in the UFS Department of Private Law and a member of the IISLT Planning Committee, emphasised the importance of interdisciplinary approaches to address land tenure security issues. She stated, "Security of land tenure requires an interdisciplinary approach that is conscious of the intersectionalities between property, environmental law and conservation, customary law and succession, gender and traditional practices, natural resources and socio-economic rights, development, agriculture and land reform, poverty, politics and governance. It is time for innovative holistic rights-based solutions."

The conference proudly collaborates with international and national research partners such as Anglia Ruskin University in London, England; Imo State University in Owerri, Nigeria, the National University of Lesotho's United Nations Development Programme Human Rights Chair, Lesotho; the Law Faculty of the University of Ilorin, Nigeria; the University of Stellenbosch, Department of Private Law,  and the Free State Centre for Human Rights. Other closely associated research collaborators are Public Affairs Research Institute and the UFS Centre for Development Studies.

The International Interdisciplinary Security of Land Tenure Conference presents a unique platform for stakeholders to engage in critical discussions, share insights, and propose innovative solutions towards securing land rights for rural communities and fostering sustainable development. Join us for this pivotal event aimed at transforming the rural land economy for the betterment of society. The conference is strongly aligned with Vision 130 and the Sustainable Development Goals (8) Economic growth, (10) Reduced inequalities, (11) Sustainable communities, and (15) Life on land.

Contact information:

For general enquiries, contact Riekie Viljoen via email at viljoenr@ufs.ac.za.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept